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Tuberculosis (TB) cellular immune responses were examined in breastmilk of 
HIV-infected mothers using the T-SPOT.TB interferon gamma release assay 
(IGRA).  Positive TB IFN-γ responses were detected in 6 of 8 (75%) valid breast 
milk assays.  Among 7 mothers with paired breastmilk and blood assays, TB IFN-
γ responses were higher in breastmilk compared to blood (p=.02). The magnitude 
of TB IFN-γ responses in maternal breastmilk and blood were correlated.  
Elucidating the influence of breastmilk TB immune responses on infant TB 
susceptibility and immunity may inform future maternal TB vaccine strategies.  
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INTRODUCTION  1 
Cell-mediated immunity in breastmilk has been associated with protection from 2 
infectious pathogens and modulation of infant immune development.1,2  Tuberculosis 3 
(TB)-specific cellular immunity in breastmilk has not been well-characterized and its role 4 
in infant TB immunity is undefined.  Small historical studies suggest that tuberculin 5 
sensitivity can be transferred by breastmilk to infants.3,4 Breastfed infants born to 6 
tuberculin positive mothers had evidence of tuberculin sensitivity, while infants of non-7 
breastfed tuberculin positive or tuberculin negative mothers did not.4 We adapted a 8 
standardized TB interferon-gamma (IFN-γ) release assay to measure breastmilk IFN-γ 9 
responses in HIV-infected mothers and compared these to TB IFN-γ responses in 10 
peripheral blood of mothers and their infants.  11 
 12 
STUDY POPULATION AND METHODS 13 
In a historical perinatal HIV cohort, TB IFN-γ responses were measured in 14 
cryopreserved maternal breastmilk cells (BMCs) and peripheral blood mononuclear 15 
cells (PBMCs) using the T-SPOT.TB ELISPOT assay (Oxford Immunotec, Oxfordshire, 16 
UK).  This study was approved by the University of Washington Institutional Review 17 
Board and the Kenyatta National Hospital Ethics and Research Committee.  HIV-18 
infected women in Nairobi, Kenya were enrolled during pregnancy in 2002 and mother-19 
infant pairs followed monthly for one year postpartum.5  Breastmilk and peripheral blood 20 
were collected at 1 month postpartum, centrifuged, and cryopreserved in 10% dimethyl 21 
sulfoxide-90% fetal calf serum (FCS) (Sigma, St. Louis, Missouri, USA).  In 2011, 22 
cryopreserved PBMCs and BMCs were thawed and incubated for 4 hours in RPMI 1640 23 
supplemented with 10% FCS (Sigma).  Lymphocytes were counted manually in the 24 
presence of Trypan Blue and viable cells were plated at mean concentration 1.5 x 105 25 
BMCs and 2.5 x 105 PBMCs per well to perform the T-SPOT.TB assay as previously 26 
described.1,6  Infant T-SPOT.TB results from 6 months of age were available from a 27 
prior study.6 Total BMC or PBMC spot-forming cells (SFCs) were normalized to the 28 
number of spots per 2.5 x 105 cells, and an assay was considered valid if there were 29 
>20 SFCs in the positive control well.  A test was positive if >6 spots above the nil 30 
control for either antigen ESAT-6 or CFP-10 when the nil control was <10 SFCs.  If the 31 
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nil control was >10 SFCs, a test was considered positive if the SFCs for either ESAT-6 32 
or CFP-10 were at least twice the SFCs in the nil control.  33 
 34 
Statistical analyses were performed using STATA software, version 11.2 (StataCorp, 35 
College Station, Texas, USA). After exclusion of invalid assays, TB IFN-γ responses 36 
were described as dichotomous (positive/negative) and continuous (SFCs above nil) 37 
measures.  Median IFN-γ SFCs in response to ESAT-6 and CFP-10 above nil in BMCs 38 
and PBMCs were compared using Wilcoxon signed-rank tests.  Data were log-39 
transformed and Spearman’s correlation of BMC and PBMC IFN-γ responses to ESAT-6 40 
and CFP-10 were assessed.  41 
 42 
RESULTS 43 
T-SPOT.TB assays were conducted in paired BMC and PBMC specimens from 11 HIV-44 
infected mothers at one month postpartum.  Prior T-SPOT.TB results were available for 45 
10 of their infants at 6 months of life.6  Median maternal CD4 count was 676 cells/mm3.  46 
In the first 6 months postpartum, mothers exclusively breastfed for a median of 6 47 
months (IQR 3-6); one mother delayed breastfeeding initiation until 1 month postpartum.  48 
No mothers or infants were diagnosed with active TB disease during follow-up.  All 49 
infants were HIV negative by HIV DNA PCR at 6 months of age.   50 
 51 
Of 11 paired maternal BMC and PBMC assays, 8 BMC and 10 maternal PBMC assays 52 
were valid.  Of valid assays, TB IFN-γ responses to either ESAT-6 or CFP-10 were 53 
present in 6 (75%) BMCs and 4 (40%) maternal PBMCs. For BMC assays, median 54 
response to ESAT-6 was 27 SFCs (IQR 2-221) and CFP-10 was 18 SFCs (IQR 4-240).  55 
Among maternal PBMC assays, median IFN-γ response to ESAT-6 was 3 SFCs (IQR 1-56 
38) and CFP-10 was 3 SFCs (IQR 0-21) (Table 1).  Median IFN-γ response to ESAT-6 57 
and CFP-10 were higher in BMCs than PBMCs (p=0.02 for both antigens) (Figure 1a). 58 
Maternal BMC and PBMC TB IFN-γ SFCs were highly correlated (ESAT-6 r=.91, p=.005 59 
and CFP-10 r =.86, p=.01) (Figure 1b).   60 
 61 
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We previously conducted T-SPOT.TB assays on the PBMCs of 10 infants of these 62 
mothers.6  Three of 8 infants (37%) with a valid assay had a positive T-SPOT.TB result. 63 
Median infant IFN-γ response to ESAT-6 was 0 SFCs (IQR 0-4) and CFP-10 was 0 64 
SFCs (IQR 0-2).  Magnitude of infant PBMC TB IFN-γ response to ESAT-6 and CFP-10 65 
did not correlate with maternal BMCs (r=.53, p=.36 and r=0, p>.9, respectively).  Of 5 66 
mother-infant pairs with valid assays, 3 were positive in both maternal BMC and infant 67 
PBMC, 1 was negative in both maternal BMC and infant PBMC, and 1 pair was 68 
discordant (maternal BMC positive, infant negative in pair with delayed breastfeeding). 69 
 70 
DISCUSSION  71 
In this proof of concept study, we measured TB-specific cellular immunity in breastmilk 72 
using the T-SPOT.TB assay. We found TB IFN-γ responses in breastmilk cells of most 73 
HIV-infected mothers examined.  Breastmilk IFN-γ responses to ESAT-6 and CFP-10 74 
were of higher magnitude and strongly correlated with maternal PBMC IFN-γ responses.   75 
 76 
Measurement of TB IFN-γ in breastmilk may be useful in future prospective studies to 77 
determine if breastmilk cell-mediated immunity may alter infant TB immunity or TB 78 
susceptibility.  TB-specific immune cells in breastmilk could provide passive infant TB 79 
protection in the oral or respiratory mucosa or enhance development of infant TB 80 
immune responses.  Maternal immunity may shape antigen sensitization, as observed 81 
in children aged 12 to 36 months who were tuberculin positive after breastfeeding from 82 
tuberculin positive mothers.3  We did not find a significant association between maternal 83 
breastmilk and longitudinal infant TB IFN-γ production. However our finding that 4 of 5 84 
mother-infant pairs had concordant TB IFN-γ responses in maternal breastmilk and 85 
infant blood at 6 months of age is intriguing.   86 
 87 
Use of cryopreserved samples may have decreased T-SPOT.TB assay sensitivity7, and 88 
small sample size limits the generalizability of our findings.  Future studies to determine 89 
whether and how breastmilk TB cellular immunity influences infant immunity and 90 
susceptibility to TB will be important, and may inform complementary maternal vaccine 91 
strategies that potentially enhance protection of infants via breastmilk. 92 
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Table 1: IFN-γ SFCs per 2.5 x 105 cells in response to M. tuberculosis in BMCs and maternal and infant 
PBMCs 
 
ID Cells PHA ESAT-6 CFP-10 Nil Result Breastfed* 
(months) 
189 
Maternal BMC 2432 7.5 15 2.5 Positive  
Maternal PBMC 888 0 0 0 Negative  
 Infant PBMC  211 169 2 0 Positive  6 
       
181 
Maternal BMC 48 5 9 0 Positive  
Maternal PBMC 665 3 3 0 Negative  
 Infant PBMC  200 20 44 16 Positive 6 
       
143 
Maternal BMC 1661 0 0 0 Negative  
Maternal PBMC 348 0 0 0 Negative   
Infant PBMC  0 4 4 4 Invalid  6 
       
134 
Maternal BMC 1207 373 297 17 Positive  
Maternal PBMC 474 83 204 0 Positive  
Infant PBMC  nd nd nd nd nd 5 
      
194 
Maternal BMC 168 0 0 0 Negative  
Maternal PBMC 1 0 0 0 Invalid  
 Infant PBMC  288 0 1 0 Negative 2 
       
173 
Maternal BMC 0 0 0 0 Invalid  
Maternal PBMC 921 1 1 0 Negative  
 Infant PBMC  708 24 52 77 Negative 6 
       
141 
Maternal BMC 1 0 0 0 Invalid  
Maternal PBMC 961 59 31 0 Positive  
Infant PBMC  0 0 0 0 Invalid 6 
       
118 
Maternal BMC 1087 744 488 115 Positive   
Maternal PBMC 625 38 21 0 Positive  
Infant PBMC  93 235 28 4 Positive 1 
       
113 
Maternal BMC 458 86 24 0 Positive   
Maternal PBMC 576 39 6 1 Positive  
Infant PBMC  69 0 0 0 Negative 3 ¶ 
       
140 
Maternal BMC 800 50 200 0 Positive  
Maternal PBMC 973 4 4 0 Negative   
Infant PBMC  6 0 0 0 Invalid 3 
       
107 
Maternal BMC 0 0 0 0 Invalid  
Maternal PBMC 861 1 0 0 Negative   
Infant PBMC  82 0 0 0 Negative 6 
       
*Months mother reported exclusive breastfeeding during the first 6 months postpartum;  
¶ Mother delayed initiation of breastfeeding until 1 month postpartum; nd = not done 
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Figure 1: Magnitude and correlation of IFN-γ response to ESAT-6 and CFP-10 in 
Maternal BMCs and PBMCs. A. The T-SPOT.TB assay was performed on 
maternal PBMCs and BMCs.  SFCs per 2.5 x 105 cells in response to antigens 
ESAT-6 (closed circles) and CFP-10 (open circles) are shown after subtraction of 
background in the nil control.  Horizontal lines represent the median.  Differences 
were determined using the Wilcoxon signed-rank test.  B. Data were log-
transformed and Spearman’s correlation of BMC and PBMC IFN-γ responses to 
ESAT-6 (closed circles) and CFP-10 (open circles) were assessed. 
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